{"filings":[{"id":109295,"accession_number":"0001193125-26-102144","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-03-11T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco beats profitability goals in FY2025; reduces leverage to 3.0x; provides FY2026 outlook","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $1.5B (-2.4% YoY); comps -1.6%; Adjusted EBITDA $106.3M (+10.6%), above outlook.","Full year net sales $6.0B (-2.5%); net income $9.1M vs loss of $101.8M; Adjusted EBITDA $408.2M (+21.3%).","Leverage ratio improved from 4.2x to 3.0x; debt refinanced with $900M term loan and $600M bond, maturities extended to 2031.","FY2026 guidance: net sales flat to +1.5% YoY; Adjusted EBITDA $415M-$430M; Q1 Adjusted EBITDA $92M-$94M.","Free cash flow $187M, up 276.3%; inventory down 9.7%; net store closures ~15-20 for FY2026."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":5961467000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109294,"accession_number":"0001193125-26-033750","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Petco completes debt refinancing; Glenn Murphy transitions to Chairman of Board","event_type":"other_material","confidence":"high","bullets":["Debt refinancing closed Feb 2; previously announced; aims to reduce leverage and increase financial flexibility.","Glenn Murphy transitions from Executive Chairman to non-employee Chairman of the Board effective Feb 1, 2026.","Murphy receives $9,615.38 lump sum statutory pay and remains eligible for FY2025 annual bonus.","CEO cites strengthened economic model, significant profitability improvement, and improved cash flow."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109293,"accession_number":"0001193125-26-033607","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Petco refi with $900M term loan and $600M 8.25% senior secured notes due 2031","event_type":"debt","confidence":"high","bullets":["$900M refinancing term loans at Term Benchmark + 4.25% (0% floor), maturing Feb 2031 with 1% annual amortization.","$600M 8.250% senior secured notes due 2031 issued; proceeds to repay existing term loan facility.","Notes carry covenants limiting additional debt, dividends, investments, asset sales, liens, and affiliate transactions.","Notes redeemable at make-whole premium before Feb 1, 2028; thereafter at specified redemption prices.","Combined proceeds from term loans, notes, and cash on hand used to fully repay existing term loan facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109292,"accession_number":"0001193125-26-019795","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco prices $600M 8.25% senior secured notes due 2031 to refinance term loan","event_type":"debt","confidence":"high","bullets":["$600M aggregate principal of 8.250% senior secured notes due February 1, 2031.","Closing expected February 2, 2026, subject to customary conditions.","Proceeds, with new term loan and cash, to repay existing term loan, pay fees, and for general corporate purposes.","Notes secured by first-lien on fixed assets and second-lien on current assets.","Notes offered only to QIBs and non-U.S. persons under Rule 144A/Regulation S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109291,"accession_number":"0001193125-26-017351","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-01-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco announces $650M senior secured notes offering due 2031 to refinance term loan","event_type":"debt","confidence":"high","bullets":["$650M aggregate principal of senior secured notes due 2031; guaranteed by Petco's subsidiary guarantors.","Notes secured first-lien on fixed assets and second-lien on current assets.","Proceeds, plus new term loan borrowings and cash, to repay existing term loan facility in full.","Offering conducted under Rule 144A/Reg S; notes not registered under Securities Act.","Completion subject to pricing and customary closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109290,"accession_number":"0001193125-26-009852","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco launches $1.5B debt refinancing, reaffirms FY2025 outlook","event_type":"debt","confidence":"high","bullets":["Intends to refinance $1.5 billion of its current term loan to extend maturities; subject to market conditions.","Completed $50M voluntary prepayment in Dec 2025; up to $100M additional authorized by board.","Reaffirms FY2025 Net Sales down 2.5%-2.8%; Adjusted EBITDA $395M-$397M.","Reaffirms Q4 2025 Adj. EBITDA $93M-$95M; Net Sales down low single digits YoY.","CEO cites fiscal 2025 execution and category resilience; no assurances refinancing will be completed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125784,"accession_number":"0001193125-25-297206","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-11-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q3 net sales down 3.1% to $1.5B, adjusted EBITDA up 17% to $98.6M; raises FY2025 adjusted EBITDA guidance","event_type":"earnings","confidence":"high","bullets":["Net sales $1.5B, down 3.1% YoY; comparable sales down 2.2% YoY.","GAAP net income of $9.3M, up $26.0M YoY.","Adjusted EBITDA increased $17.3M to $98.6M.","FY2025 adjusted EBITDA guidance raised to $395M-$397M, midpoint increased $6M.","Gross profit margin expanded 75bps to 38.9% of net sales."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":4446339000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142512,"accession_number":"0001826470-25-000010","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-08-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q2 net sales down 2.3% YoY, EBITDA up; raises FY2025 earnings outlook","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $1.5B (-2.3% YoY); comparable sales -1.4%; gross margin expanded 120bps to 39.3%.","GAAP net income $14.0M (improved $38.8M); Adjusted EBITDA $113.9M (+$30.3M).","Full year FY2025 outlook: net sales down low single digits; Adj. EBITDA raised to $385M-$395M; net store closures ~25.","Q3 FY2025 outlook: Adj. EBITDA $92M-$94M; net sales down low single digits.","CEO Joel Anderson: 'first half established solid foundation for transformation; raising earnings outlook.'"],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":2981928000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142511,"accession_number":"0001826470-25-000005","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-08-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco to present at Goldman Sachs Global Retailing Conference on Sept. 4, 2025","event_type":"other","confidence":"high","bullets":["Presentation scheduled for Thursday, Sept. 4, 2025 at approximately 1:50 p.m. Eastern Time.","Live webcast available on Petco's investor relations page at ir.petco.com.","Replay will be available through same link approximately two hours after the presentation.","No financial results or guidance were disclosed in this announcement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142510,"accession_number":"0000950170-25-099616","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-07-29T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Petco shareholders re-elect three directors, approve executive compensation, ratify EY as auditor","event_type":"other_material","confidence":"high","bullets":["R. Michael Mohan: 225.7M votes for (95.8% of votes cast); David Lubek: 213.1M for; Christopher J. Stadler: 207.6M for.","Advisory vote on named executive officer compensation passed with 221.2M for, 14.4M against, 148.5K abstentions.","Ratification of Ernst & Young as independent auditor for FY ending Jan 31, 2026: 254.5M for, 2.3M against, 284K abstentions.","Broker non-votes of 21.4M shares on Proposals 1 and 2; none on Proposal 3."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160550,"accession_number":"0000950170-25-082319","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q1 net sales down 2.3% to $1.5B; net loss improves to $11.7M; reaffirms FY2025 outlook","event_type":"earnings","confidence":"high","bullets":["Net sales $1.5B, down 2.3% YoY; comparable sales -1.3%; gross margin +30bps to 38.2%.","Operating income improved $33.1M to $16.4M; GAAP net loss improved $34.8M to $11.7M.","Adjusted EBITDA rose $13.8M to $89.4M, ahead of guidance.","Q2 2025 outlook: net sales down low single digits YoY; Adj. EBITDA $92-$94M.","FY2025 outlook reaffirmed: Adj. EBITDA $375-$390M; capex $125-$130M; assumes tariffs at current levels."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":1493399000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160549,"accession_number":"0000950170-25-076991","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Christy Lake to resign from Petco Board at 2025 annual meeting; Board size reduced to 10","event_type":"leadership","confidence":"high","bullets":["Christy Lake resigned from the Board and compensation committee, effective at the 2025 Annual Meeting of Stockholders.","Lake will not stand for re-election; departure is not due to any disagreement with Petco.","Board reduced its size from 11 to 10 directors, effective immediately after the Annual Meeting.","Lake is expected to remain on the Board and compensation committee until the meeting date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}